申请人:Eli Lilly and Company
公开号:US04224442A1
公开(公告)日:1980-09-23
Cephalosporin antibiotics of the formula ##STR1## wherein R is ##STR2## and R" is H, C.sub.1 -C.sub.3 alkyl, allyl, propargyl, C.sub.3 -C.sub.6 cycloalkyl, phenyl, benzyl or furfuryl; R' is H or methyl; or R is a cyclic urea group for example, R is ##STR3## R.sub.1 is phenyl, thienyl, or furyl; R.sub.3 is a lower alkyl substituted 1H-tetrazole-5-thio or 1,3,4-thiadiazole-5-thio group and R.sub.4 is hydrogen or an active ester group, e.g., an acetoxymethyl group; are highly active broad spectrum antibiotics especially useful in the treatment of infections attributable to the gram-negative microorganisms.
头孢菌素抗生素的化学式为##STR1##其中R为##STR2##,R"为H,C.sub.1 -C.sub.3烷基,烯丙基,丙炔基,C.sub.3 -C.sub.6环烷基,苯基,苄基或呋喃基;R'为H或甲基;或者R为环脲基,例如,R为##STR3## R.sub.1为苯基,噻吩基或呋喃基;R.sub.3为较低烷基取代的1H-四唑-5-硫基或1,3,4-噻二唑-5-硫基团,R.sub.4为氢或活性酯基团,例如,乙酰氧甲基基团;这些头孢菌素抗生素是高活性的广谱抗生素,特别适用于治疗由革兰阴性微生物引起的感染。